Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Sanfran, does this not also suggest a quick and high probability of success of the approval of the BETonMACE phase 3 trial for rvx-208 since it is an epigenetic drug? I would think so. There should be announcements soon IMHO.